Superbug surcharge: The economics of MDROs and HAIs
23 Sept 2025Multidrug-resistant organisms (MDROs) and healthcare-associated infections (HAIs) threaten patient health and impose significant financial burdens on healthcare systems, necessitating extended hospital stays and costly treatments. Consequently, there is an urgent need for proactive solutions to combat these escalating threats.
This infographic illustrates the financial toll in the U.S., Europe, and globally, while highlighting diagnostic innovations that help reduce risks, improve patient care, and strengthen antimicrobial stewardship.
Download this infographic to explore how to:
- Understand the global economic burden created by multidrug‑resistant organisms (MDROs) and healthcare‑associated infections (HAIs).
- Recognize how MDROs and HAIs worsen patient outcomes and extend hospital stays.
- Explore regional data illustrating the worldwide scale and financial impact of antimicrobial resistance.
- Learn how diagnostic innovations can support earlier detection and strengthen antimicrobial stewardship programs.
Resource details:
- Document type: Infographic
- Page count: 1
- Read time: 1.5 mins
Related Products
Request Quote for All Products
Thermo Scientific™ Sensititre™ ARIS HiQ™ System for AST
Thermo Fisher ScientificAchieve the comprehensive, accurate MIC values needed to guide more targeted patient therapy with the Thermo Scientific™ Sensititre™ ARIS HiQ™ System, a benchtop automated incubation and reading system for antimicrobial susceptibility testing and identification of bacterial pathogens; designed to accommodate up to 100 Sensititre™ microtitre plates within a single instrument.